The Breeders' Cup has revised its "Convicted Trainer Rule" and will impose a minimum one-year suspension from the World Championships on any trainer with a Class 2, Category A, violation during the preceding 12 months.
Kentucky Horse Racing Commission officials acknowledged concerns about aspects of the proposed out-of-competition testing of racehorses and pledged Aug. 25 to consider the input before the regulations are approved.
- By Tom LaMarra
Anti-Doping Research Inc., which oversees the non-profit Equine Drug Research Institute in California, has developed a test for CERA, a blood-doping agent.
None of the horses that participated in this year's Breeders' Cup World Championships Oct. 24-25 at Santa Anita tested positive for steroids, blood-doping agents or TCO2 (bicarbonate).
The out-of-competition tests for EPO ordered by the New Jersey Racing Commission on 41 of trainer Bruce Levine's horse at Monmouth Park came back negative.
Bruce Levine, the leading trainer at Monmouth Park, had his entire stable of 41 horses tested for erythropoietin, commonly known as EPO, by a New Jersey state veterinarian who made a surprise visit to Levine's Monmouth barn June 24 at the request of the New Jersey Racing Commission.
The random out-of-competition testing of Breeders' Cup World Championships participants for Epogen (EPO) and total carbon dioxide (TCO2) have all returned negative, officials announced Oct. 24.
By Joe Gorajec - If a drug existed that enhanced performance yet was undetectable by traditional testing methods would it pose a clear and present danger to the integrity of our sport? Would some trainers succumb to the lure of success and easy money knowing they could cheat with impunity? The answers seem obvious.
The New Jersey Racing Commission Sept. 17 approved regulations to conduct, for the first time, out of competition testing for EPO (Epogen) and TCO2 testing in Thoroughbred racehorses competing at the four New Jersey racetracks.
Members of the Breeders' Cup Members and Trustees and the Board of Directors discussed a proposal before the state of New Jersey, home to Monmouth Park, site of the 2007 Breeders' Cup World Championships, to conduct out of competition testing for erythropoietin (EPO).
The 20 starters for the May 5 Kentucky Derby Presented by Yum! Brands (gr. I) were tested for the performance-enhancing drug erythropoietin (EPO) May 2.
The Delaware Thoroughbred Racing Commission will issue hefty fines and lengthy suspensions for anyone caught using blood-doping agents effective April 10.
Delaware is taking a harder line on use of erythropoietin and similar blood-doping agents.
Kentucky has performed random testing for blood-doping antibodies in racehorses of all breeds for more than a year, but now it's testing for the actual proteins, a process that could put more teeth in penalties.
A Pennsylvania laboratory is the first to employ a definitive test for erythropoietin--the blood-doping agent commonly known as EPO--and the test resulted in the suspension and fining of a trainer of Standardbreds in Ontario, Canada.
- By Ray Paulick
By Ray Paulick - Human sports and racing have faced the same challenge: the cheaters are ahead of the labs.
The Louisiana State Racing Commission's medication committee has asked the full commission to ban the use and possession of human recombinant erythropoietin (EPO) and darbepoietin, as well as consider measures aimed at random pre-race testing for total dissolved carbon dioxide, more commonly known as "milkshaking."
The Indiana Horse Racing Commission April 21 called for an economic impact study on the impact of having--or not having--Kentucky signals available at the state's racetracks and off-track betting parlors.
Delaware, beginning May 11, will join New York and Ontario, Quebec, as jurisdictions with rules to penalize horses that test positive for erythropoietin antibodies.
The Arizona Department of Racing approved a pilot program for equine "milkshake" testing and increased the number of ELISA tests to 25 from 15.
The Arkansas Racing Commission began testing for erythropoietin antibodies Sunday as part of a series of changes to the state's medication rules.
Industry officials, during a preliminary meeting Dec. 2 at Philadelphia Park, discussed testing for erythropoietin antibodies that could be implemented in Pennsylvania and perhaps a few other Mid-Atlantic states in 2004.
The first week of testing for erythropoietin (EPO) antibodies in New York, which began Nov. 1, produced zero positive results, a spokesperson for the New York State Racing and Wagering Board said Wednesday.
The racing commissions that govern Thoroughbred and Standardbred racing in Delaware have been testing for erythropoietin antibodies since June 1, and in the future may implement rules to penalize horses that test positive.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
New York regulators Oct. 21 gave final approval to a new rule authorizing the testing of post-race samples for performance-enhancing erythropoetin antibodies. The New York Racing and Wagering Board said the testing would begin Nov. 1, which would make New York the first state to require the test.
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
Two horses that raced at Lone Star Park April 13 tested positive for erythropoietin (EPO) antibodies, which brings the total number of horses to test positive in Texas this year to eight.
The largest out-of-competition drug-testing raid in Australian history Monday at Randwick racecourse produced no positive tests. The practice was introduced in Australia last October.
Uniformity in medication and drug testing could be years away, a member of the Racing Medication and Testing Consortium said April 1 during a California Horse Racing Board Medication Committee meeting.
- By Gary West
By Gary West -- Positive tests detecting the presence of EPO antibodies in horses pose an integrity problem for racing that is far graver than the Breeders' Cup Ultra Pick 6 scam.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Though testing for the blood-doping agent erythropoietin (EPO) remains in its infant stages, a view into the prevalence of the drug on North America's backstretches is beginning to come into focus.
Antibodies for the blood-doping agent erythropoietin (EPO) have been detected in 12 horses in Louisiana over the past month, the state's racing laboratory confirmed on Monday.
Antibodies for erythropoeitin, a blood-doping substance commonly known as EPO, were found in six racehorses at Sam Houston Race Park, the Dallas Morning News reported Feb. 18.
The Kentucky Racing Commission has decided to form a committee to explore the testing of horses on days they're not scheduled to race. The decision stems from an earlier classification of erythropoeitin and the process of blood-doping as a prohibited practice.
The Kentucky Equine Drug Council will ask the Kentucky Racing Commission Jan. 15 to form a committee to tackle the complicated and controversial issue of out-of-competition testing.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
Industry representatives in West Virginia met by teleconference Oct. 15 to devise emergency rules to govern use of adjunct bleeder medications and to ban the practice of blood-doping.
Erythropoietin (EPO), a human medication designed to increase the concentration of red blood cells that is rumored to be in use on racehorses, has been added to the list of prohibited veterinary substances on racing premises by the California Horse Racing Board.
The Pennsylvania State Horse Racing Commission has issued an advisory that erythropoietin, or EPO, and other blood-doping substances and procedures are not permitted in the state.
The Kentucky Racing Commission said June 25 it would consider at its next meeting in September a motion to make the possession or use of erythropoietin, known as EPO, a prohibited practice.
The Los Angeles County Fair's desire to move its September racing meet to Santa Anita Park has become a referendum on Magna Entertainment Corp.'s control of California racing dates.
By Barry Irwin -- If you want to know which illegal drugs might appear next in horse racing, consider that every drug which has found its way into horse racing was first used in track and field or cycling.
The New South Wales Racing Laboratory has developed a test to detect the drug erythropoietin, commonly known as EPO, in racehorses, according to release on the Racing New South Wales Web site. The medication is considered a performance-enhancer.
Most Popular Stories
- Baffert Quartet Faces Shared Belief in Malibu
- Champion High Chaparral Euthanized at 15
- Awesome Baby Heads Speedy Field in La Brea
- Gulfstream Builds Stalls for Displaced Horses
- Los Alamitos Concludes Successful Winter Meet
- Dortmund Wins Dramatic Los Alamitos Futurity
- Clement Trio Looms Large in La Prevoyante
- Strong Field Set for Mathis Brothers Mile
- Divine Oath, North Slope Meet in McKnight
- Speechify Goes for Grade in Mr. Prospector